According to groundbreaking research from Rutgers University–Camden, South Jersey families receiving assistance from the Whole Families Approach, a program that pools social-service providers together in an effort to offer improved support, have experienced better outcomes than non-participants.
Three Rutgers University researchers seek to address important gaps in understanding not only the cognitive, neural, and immunological consequences of COVID-19 in older African Americans but also how those consequences can impact this population’s risk for Alzheimer’s Disease.
A rapid test that detects all known COVID-19 variants, including the highly transmissible Omicron variant, has been developed by researchers at Rutgers New Jersey Medical School.
A Rutgers study gives new insight into the experiences and perspectives of Black and Latinx people working in supportive health care roles during the COVID-19 pandemic.
Rutgers Robert Wood Johnson Medical School (RWJMS) is projected to receive approximately $30 million, establishing a critical partnership with the larger National Institutes of Health-funded RECOVER initiative to study long-term and delayed impacts of COVID-19 in children and lead a national collaboration with the potential to recruit from any state to investigate these outcomes.
Nearly 1 in 5 people in the United States over the age of 12 haven’t gotten at least one shot. Some may be reluctant to take a vaccine they believe has only been tested for a few months, but that couldn’t be further from the truth, says Michelle Carlin, an assistant professor of forensic chemistry at Rutgers University–Camden.
Rutgers, a clinical trial site for the global Pfizer-BioNTech research study to evaluate the efficacy of its COVID-19 vaccine in children, is looking for participants for a third clinical trial on children ages 6 months to 4 years.